An Old Bridge to the Newer Biologics: Cyclosporine for Rescue Therapy in Acute Severe Ulcerative Colitis.
作者信息
Ashat Divya, Jain Animesh, Weaver Kimberly N, Long Millie D, Herfarth Hans H, Barnes Edward L
机构信息
Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Campus Box #7080, 130 Mason Farm Road, Chapel Hill, NC, 27599-7080, USA.
Multidisciplinary Center for Inflammatory Bowel Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
出版信息
Dig Dis Sci. 2022 Dec;67(12):5439-5443. doi: 10.1007/s10620-022-07682-7. Epub 2022 Sep 20.
Abstract
摘要
相似文献
1
An Old Bridge to the Newer Biologics: Cyclosporine for Rescue Therapy in Acute Severe Ulcerative Colitis.
Dig Dis Sci. 2022 Dec;67(12):5439-5443. doi: 10.1007/s10620-022-07682-7. Epub 2022 Sep 20.
2
Management of Acute Severe Colitis in Children With Ulcerative Colitis in the Biologics Era.
Pediatrics. 2016 May;137(5). doi: 10.1542/peds.2015-1184.
3
Rescue Therapies for Steroid-refractory Acute Severe Ulcerative Colitis: A Review.
J Crohns Colitis. 2023 Jun 16;17(6):972-994. doi: 10.1093/ecco-jcc/jjad004.
4
Efficacy of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for Acute Severe Ulcerative Colitis.
Clin Gastroenterol Hepatol. 2023 May;21(5):1354-1355.e2. doi: 10.1016/j.cgh.2022.03.008. Epub 2022 Mar 17.
5
Integrating efficacy and safety of vedolizumab compared with other advanced therapies to assess net clinical benefit of ulcerative colitis treatments: a network meta-analysis.
Expert Rev Gastroenterol Hepatol. 2021 Jun;15(6):711-722. doi: 10.1080/17474124.2021.1880319. Epub 2021 Mar 4.
6
[Biologics treatment for ulcerative colitis].
Nihon Shokakibyo Gakkai Zasshi. 2013 Nov;110(11):1909-15.
7
Clinical outcomes with ustekinumab as rescue treatment in therapy-refractory or therapy-intolerant ulcerative colitis.
United European Gastroenterol J. 2020 Feb;8(1):91-98. doi: 10.1177/2050640619895361. Epub 2019 Dec 12.
8
Identification of the Most Cost-effective Position of Vedolizumab Among the Available Biologic Drugs for the Treatment of Ulcerative Colitis.
J Crohns Colitis. 2020 Jun 19;14(5):575-587. doi: 10.1093/ecco-jcc/jjz212.
9
Cyclosporine for severe steroid-refractory ulcerative colitis: commenting the comment.
Minerva Gastroenterol Dietol. 2018 Sep;64(3):190-192. doi: 10.23736/S1121-421X.18.02462-5. Epub 2018 Jan 10.
10
Biologic Therapy for Ulcerative Colitis.
Gastroenterol Clin North Am. 2020 Dec;49(4):717-729. doi: 10.1016/j.gtc.2020.08.002. Epub 2020 Sep 26.
引用本文的文献
1
Recent Advances in the Management of Acute Severe Ulcerative Colitis.
J Clin Med. 2024 Dec 6;13(23):7446. doi: 10.3390/jcm13237446.
2
What to do when traditional rescue therapies fail in acute severe ulcerative colitis.
Intest Res. 2024 Oct;22(4):397-413. doi: 10.5217/ir.2024.00003. Epub 2024 May 16.
本文引用的文献
1
Combining Cyclosporine With Ustekinumab in Acute Severe Ulcerative Colitis.
ACG Case Rep J. 2021 May 14;8(5):e00604. doi: 10.14309/crj.0000000000000604. eCollection 2021 May.
2
Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-Refractory Ulcerative Colitis: Systematic Review and Network Meta-Analysis.
J Crohns Colitis. 2021 May 4;15(5):733-741. doi: 10.1093/ecco-jcc/jjaa226.
3
Successful cyclosporin and ustekinumab combination therapy in a patient with severe steroid-refractory ulcerative colitis.
Therap Adv Gastroenterol. 2020 Oct 10;13:1756284820954112. doi: 10.1177/1756284820954112. eCollection 2020.
4
Letter: ciclosporin and vedolizumab for steroid-refractory ulcerative colitis.
Aliment Pharmacol Ther. 2020 Aug;52(3):578-579. doi: 10.1111/apt.15896.
5
AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis.
Gastroenterology. 2020 Apr;158(5):1465-1496.e17. doi: 10.1053/j.gastro.2020.01.007. Epub 2020 Jan 13.
6
Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid-refractory ulcerative colitis.
Aliment Pharmacol Ther. 2020 Mar;51(6):637-643. doi: 10.1111/apt.15616. Epub 2019 Dec 25.
7
ACG Clinical Guideline: Ulcerative Colitis in Adults.
Am J Gastroenterol. 2019 Mar;114(3):384-413. doi: 10.14309/ajg.0000000000000152.
8
Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe.
J Crohns Colitis. 2019 Sep 19;13(9):1105-1110. doi: 10.1093/ecco-jcc/jjz032.
9
A Practical Guide to the Safety and Monitoring of New IBD Therapies.
Inflamm Bowel Dis. 2019 Apr 11;25(5):831-842. doi: 10.1093/ibd/izy313.
10
Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis.
Clin Gastroenterol Hepatol. 2019 Feb;17(3):494-501. doi: 10.1016/j.cgh.2018.08.081. Epub 2018 Sep 10.
Zotero 插件